Last update 01 Nov 2024
Bayer Pharmaceuticals Pvt Ltd.
Subsidiary Company|
1998|
India
Last update 01 Nov 2024
Overview
Tags
Neoplasms
Nervous System Diseases
Other Diseases
Diagnostic radiopharmaceuticals
Radiolabeled antibody
Radionuclide Drug Conjugates (RDC)
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Active surveillance of the safety of Gadolinium-based contrast agent(s) in India - NIL
Phase 3 study to investigate the efficacy and safety of the oral FXIa inhibitor Asundexian (BAY 2433334) compared with placebo in participants after an acute noncardio embolic ischemic stroke or high-risk TIA.
A multicenter, international, randomized, active comparator-controlled, double-blind, doubledummy,parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oralFXIa inhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke orsystemic embolism in male and female participants aged 18 years and older with atrialfibrillation at risk for stroke - OCEANIC-AF
100 Clinical Results associated with Bayer Pharmaceuticals Pvt Ltd.
Login to view more data
Login to view more data
100 Deals associated with Bayer Pharmaceuticals Pvt Ltd.
Login to view more data
100 Translational Medicine associated with Bayer Pharmaceuticals Pvt Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 14 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Approved
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free